Browsing Category

24267 posts

Mariah Carey's 'Here For It All' Becomes Her Most-Streamed Studio Album Launch in China

HANGZHOU, China, Nov. 7, 2025 /PRNewswire/ — Mariah Carey’s Here For It…
Mantle Collaborates with Bybit and Backed to Bring U.S. Equities Onchain, Pioneering Next Trillion-Dollar Wave of Tokenized Assets

Mantle Collaborates with Bybit and Backed to Bring U.S. Equities Onchain, Pioneering Next Trillion-Dollar Wave of Tokenized Assets

DUBAI, UAE, Nov. 7, 2025 /PRNewswire/ — Mantle, the high-performance distribution and…
Symbiotic Cosmos: A Dialogue on Reconstructing Design Education Ecosystem Amidst Technological Iteration

Symbiotic Cosmos: A Dialogue on Reconstructing Design Education Ecosystem Amidst Technological Iteration

HANGZHOU, China, Nov. 7, 2025 /PRNewswire/ — The China (Hangzhou) Art and…
HiBy RS8 II Ultra-Flagship Portable HiFi Player Released

HiBy RS8 II Ultra-Flagship Portable HiFi Player Released

LEWES, Del., Nov. 7, 2025 /PRNewswire/ — HiBy has officially launched its…
Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025

Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025

Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune…
Bitget Slashes Stock Futures Trading Fees by 90% as Daily Volume Surpasses 0 Million

Bitget Slashes Stock Futures Trading Fees by 90% as Daily Volume Surpasses $300 Million

VICTORIA, Seychelles, Nov. 7, 2025 /PRNewswire/ — Bitget, the world’s largest Universal…

Anchoring the 15th Five-Year Plan: China's High-quality Development is Strengthening Foreign Investors' Confidence

BEIJING, Nov. 7, 2025 /PRNewswire/ — A news report from China.org.cn on the…
HanchorBio Presents Two Late-Breaking Abstracts at the Society for Immunotherapy of Cancer 2025 Demonstrating Best-in-Class Potential of HCB101 in Advanced Cancers

HanchorBio Presents Two Late-Breaking Abstracts at the Society for Immunotherapy of Cancer 2025 Demonstrating Best-in-Class Potential of HCB101 in Advanced Cancers

Late-breaking poster presentations show HCB101’s favorable safety, strong receptor occupancy, and promising…